What are the first-line pharmacologic treatments and appropriate dosages for an adult patient presenting with fatigue, decreased enthusiasm, and low libido?

Pharmacologic Treatment for Low Energy, Enthusiasm, and Low Libido

Do not initiate testosterone treatment for improving energy and vitality, as guidelines explicitly recommend against this use; instead, address these symptoms through evaluation for underlying depression and consider dopaminergic/noradrenergic agents if depression is confirmed. 1

Primary Recommendation: Testosterone is NOT Indicated for Energy/Vitality

The 2020 American College of Physicians guideline is unequivocal: clinicians should NOT initiate testosterone treatment in men with age-related low testosterone to improve energy, vitality, physical function, or cognition 1. This is a conditional recommendation based on low-certainty evidence, but it directly addresses your question about low energy and enthusiasm.

When Testosterone MAY Be Considered (Sexual Function Only)

Testosterone should only be discussed for sexual dysfunction specifically (erectile dysfunction, decreased libido) in men with documented age-related low testosterone who want to improve sexual function 1. If you pursue this route:

• Intramuscular formulations are preferred over transdermal due to significantly lower costs with similar efficacy and safety profiles 1
• Common IM dosing: testosterone undecanoate 160 mg/day has been studied 2
• Reevaluate at 12 months and discontinue if no improvement in sexual function 1
• The FDA only approves testosterone for low levels due to known medical causes, not age-related decline 1

Alternative Approach: Evaluate for Depression

The symptom triad of low energy, decreased enthusiasm, and low libido strongly suggests underlying major depressive disorder, where fatigue occurs in over 90% of patients 3. This is the more appropriate diagnostic framework.

First-Line Pharmacologic Options for Depression-Related Fatigue

Medications with dopaminergic and/or noradrenergic action are most effective for improving fatigue and low energy 3, 4:

1. Bupropion (dopaminergic antidepressant)

   • Addresses depression, fatigue, AND has favorable sexual side effect profile 4, 5, 6
   • Dual benefit: treats underlying depression while avoiding sexual dysfunction common with SSRIs

2. Modafinil (as augmentation)

   • Effective for residual fatigue in depression 3, 4
   • Can be added to existing antidepressant therapy

3. Mirtazapine or Agomelatine

   • Associated with more favorable sexual side effect profiles compared to SSRIs 5, 6

Critical Pitfall to Avoid

Do NOT use SSRIs or SNRIs as first-line for this symptom constellation. These medications commonly cause or worsen sexual dysfunction (decreased libido, arousal difficulties, delayed orgasm) through serotonergic overactivation of 5-HT₂A/₂C receptors and dopaminergic suppression 5, 6. This would directly worsen the low libido component.

Alternative Consideration: Carnitines

If testosterone is being considered despite guideline recommendations, propionyl-L-carnitine 2g/day plus acetyl-L-carnitine 2g/day proved MORE effective than testosterone for sexual function, depression, and fatigue in a 2004 RCT of men aged 60-74 2. Importantly:

• Did NOT increase prostate volume (unlike testosterone)
• Did NOT alter PSA or hormone levels
• Improved nocturnal penile tumescence more than testosterone
• Negligible side effects

However, this is older evidence (2004) and not guideline-supported.

Algorithmic Approach

1. Screen for depression using validated tools (PHQ-9)
2. If depression present: Start bupropion as first-line antidepressant
3. If sexual dysfunction is primary complaint with documented low testosterone: Consider discussing testosterone (IM formulation), but counsel that it will NOT improve energy/vitality
4. If residual fatigue persists on antidepressant: Add modafinil or consider atomoxetine augmentation
5. Avoid SSRIs/SNRIs given the sexual dysfunction component

Key Caveat

The guideline evidence for testosterone improving energy is rated as low-certainty 1, meaning the true effect may be substantially different. However, in the absence of stronger evidence and given potential harms (prostate effects, cardiovascular concerns), the conservative approach of NOT using testosterone for energy/vitality is most appropriate for real-world clinical practice.